Lung transplant in Uruguay. Progress in motion for the consolidation of the program
Abstract
Introduction:
a program for Lung Transplant (LT) has been operative in Uruguay since 2003, by means of a bi-national agreement with Fundación Favaloro, a regional reference center in Argentina.
Method:
descriptive, retrospective study performed between 2003 and 2017. Data in the electronic register was compiled and analyzed using SPSS (Statistical Package for the Social Sciences).
Results:
70 patients were entered in the list, 27 of which underwent transplant surgery, 95% of them resumed social like and/or work. Etiologies included emphysema (33%), cystic fibrosis (26%) and idiopathic pulmonary fibrosis (11%). The most frequent complications were respiratory infections and alterations in the airway. Post-transplant mortality is 34% and conditional median survival is higher than 8 years. The increased mortality in the list (32%) encouraged development of new strategies for lung procurement. The following facts are pointed out: longitudinal follow-up of patients, modification of the calling threshold, the performance of alveolar recruitments maneuvers, the systematic performance of fibrobroncoscopy, minimization of transport times and training of the Uruguayan surgical team for ablation. Lung procurement increased from 0 per million of population (pm) in 2014 to 1.8 pmp in 2017
Conclusions:
the Uruguayan program for LT has evidenced significant progress. The last two years have been essential for the increase of lung procurement. Results, survival and morbi-mortality are comparable to those described globally. Future perspectives will focus on consolidating the program in a reference center and performing ablation and implants in our country.
References
(1) Román A, Ussetti P, Solé A, Zurbano F, Borro JM, Vaquero JM, et al. Guidelines for the selection of lung transplantation candidates. Arch Bronconeumol 2011; 47:303-9.
(2) Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, et al. The registry of the international society for heart and lung transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant 2017; 36(10):1047-59.
(3) Red/Consejo Iberoamericano de Donación y Trasplante. Newsletter Trasplante Iberoamérica 2017; XI(1). Disponible en: http://www.ont.es/publicaciones/Documents/NEWSLETTER %202017_baja%20(2).pdf [Consulta: 12 de junio de 2018].
(4) Curbelo P, Cáneva J, Ossés JM, Bertolotti A, Álvarez I, Mizraji R, et al. Programa de Trasplante Pulmonar en Uruguay. Nuestra experiencia con un centro regional de referencia. Rev Argent Med Respir 2008; 8:103-6.
(5) Curbelo P. Trasplante pulmonar: revisión. Situación en Uruguay. Arch Med Interna 2008; Supl 2:S44-8.
(6) Uruguay. Ministerio de Salud Pública. Instituto Nacional de Donación y Trasplante de Células, Tejidos y Órganos. Estadísticas (Actualizadas a diciembre 2017). 2017. Disponible en: https://www.indt.gub.uy/?S=estadisticas [Consulta: 5 de agosto de 2018]
(7) Curbelo P, Cáneva J, Chao C, Ossés JM, Vigliano C, Tommasino N, et al. Fenotipos de disfunción crónica del injerto pulmonar. Rev Am Med Respir 2018; 2:121-4.
(8) Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, Kirk R, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report—2010. J Heart Lung Transplant 2010; 29:1104-18.
(9) Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart–lung transplant report—2005. J Heart Lung Transplant 2005; 24:956-67.
(10) Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart–lung transplant report—2014; focus theme: retransplantation. J Heart Lung Transplant 2014; 33:1009-24.
(11) Miñambres E, Pérez-Villares JM, Chico-Fernández M, Zabalegui A, Dueñas-Jurado JM, Misis M, et al. Lung donor treatment protocol in brain dead-donors: a multicenter study. J Heart Lung Transplant 2015; 34:773-80.
(12) Miñambres E, Coll E, Duerto J, Suberviola B, Mons R, Cifrian JM, et al. Effect of an intensive lung donor-management protocol on lung transplantation outcomes. J Heart Lung Transplant 2014; 33:178-84.
(13) Martens A, Neyrinck A, Van Raemdonck D. Accepting donor lungs for transplant: let Lisa and Bob finish the job! Eur J Cardiothorac Surg 2016; 50:832-3.
(14) Ware LB, Wang Y, Fang X, Warnock M, Sakuma T, Hall TS, et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002; 360(9333):619-20.
(15) Costa J, Sreekanth S, Kossar A, Raza K, Lederer DJ, Robbins H, et al. Donor lung assessment using selective pulmonary vein gases. Eur J Cardiothorac Surg 2016; 50:826-31.
(16) Ware LB, Fang X, Wang Y, Babcock WD, Jones K, Matthay MA. High prevalence of pulmonary arterial thrombi in donor lungs rejected for transplantation. J Heart Lung Transplant 2005; 24:1650-6.
